Net revenue and net profit grew year-over-year in Q1 2025, with strong gross margin and liquidity. Segment performance was led by Jakarta and West Java, and capital allocation focused on hospital expansion. No significant impairments or legal risks were reported.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.